161 related articles for article (PubMed ID: 33543325)
1. Performance of [
Afshar-Oromieh A; da Cunha ML; Wagner J; Haberkorn U; Debus N; Weber W; Eiber M; Holland-Letz T; Rauscher I
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2925-2934. PubMed ID: 33543325
[TBL] [Abstract][Full Text] [Related]
2. The management impact of
Kulkarni M; Hughes S; Mallia A; Gibson V; Young J; Aggarwal A; Morris S; Challacombe B; Popert R; Brown C; Cathcart P; Dasgupta P; Warbey VS; Cook GJR
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):674-686. PubMed ID: 31872280
[TBL] [Abstract][Full Text] [Related]
3. A pictorial view on false positive findings of
Dancheva Z; Chausheva S; Stoeva T; Dyankova M; Yordanova T; Chaushev B; Marinov R; Nikolov V; Abushev P; Todorov G; Dimitrova E; Klisarova A; Anakievski D
Hell J Nucl Med; 2024; 27(1):16-26. PubMed ID: 38629815
[TBL] [Abstract][Full Text] [Related]
4. Detection efficacy of [
Rosar F; Khreish F; Marlowe RJ; Schaefer-Schuler A; Burgard C; Maus S; Petto S; Bartholomä M; Ezziddin S
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2899-2909. PubMed ID: 37148297
[TBL] [Abstract][Full Text] [Related]
5. Can the Gleason score be predicted in patients with prostate cancer? A dynamic contrast-enhanced MRI,
Akkaya H; Dilek O; Özdemir S; Taş ZA; Öztürk İS; Gülek B
Diagn Interv Radiol; 2023 Sep; 29(5):647-655. PubMed ID: 37395389
[TBL] [Abstract][Full Text] [Related]
6.
Sonni I; Dal Pra A; O'Connell DP; Ells Z; Benz M; Nguyen K; Yoon SM; Deng J; Smith C; Grogan T; Nickols NG; Cao M; Kishan AU; Calais J
J Nucl Med; 2023 Jun; 64(6):902-909. PubMed ID: 36759200
[TBL] [Abstract][Full Text] [Related]
7. Impact of
Afaq A; Alahmed S; Chen SH; Lengana T; Haroon A; Payne H; Ahmed H; Punwani S; Sathekge M; Bomanji J
J Nucl Med; 2018 Jan; 59(1):89-92. PubMed ID: 28747520
[TBL] [Abstract][Full Text] [Related]
8. Total-body [
Wang Y; Chen Z; Zhu Y; Zhao H; Li L; Huang G; Xue W; Chen R; Liu J
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4096-4106. PubMed ID: 37578502
[TBL] [Abstract][Full Text] [Related]
9. Total-body PET/CT with half-dose [
Liu Y; Li L; Qin Y; Chen Z; Zhao H; Wang X; Chen R
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):581-589. PubMed ID: 37819451
[TBL] [Abstract][Full Text] [Related]
10. Deep learning-based whole-body characterization of prostate cancer lesions on [
Huang B; Yang Q; Li X; Wu Y; Liu Z; Pan Z; Zhong S; Song S; Zuo C
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1173-1184. PubMed ID: 38049657
[TBL] [Abstract][Full Text] [Related]
11. Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [
Eur J Nucl Med Mol Imaging; ; . PubMed ID: 33341915
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
